PPIDT00110
Drug Information
| Name | Tetracosactide |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB01284 |
| Type | small molecule |
| Indication | For use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, lyophilized, for solution | Intramuscular; Intravenous; Parenteral |
0.25 mg/1mL
|
| Powder, for solution | Intramuscular; Intravenous |
0.25 mg / vial
|
| Injection, powder, for solution | Intramuscular; Intravenous |
0.25 mg/1mL
|
| Injection, powder, lyophilized, for solution | Intramuscular; Intravenous |
0.25 mg/1mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
0.25 mg/1mL
|
| Injection, solution | Intravenous |
0.25 mg/1mL
|
| Injection, solution | Intravenous |
|
| Injection, suspension | Intramuscular |
1 MG/ML
|
| Solution | Intramuscular; Intravenous |
0.25 mg/1ml
|
| Suspension | Intramuscular |
1 mg / mL
|
| Injection, suspension | Intramuscular |
1 mg
|